Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Bipolar Disord. 2012 Feb;14(1):90–98. doi: 10.1111/j.1399-5618.2012.00983.x

Table 1.

Characteristics of the experimental (tree or ragweed pollen antigen-specific IgE positive status) and control (IgE negative status) groups are presented

Characteristic All patients (n = 94) IgE positive (n = 41) IgE negative (n = 53) p-value
Age, years, mean (SD) 43.8 (10.4) 39.9 (9.7) 46.8 (9.9) 0.001
Gender, male, n (%) 40 (42.6) 19 (46.3) 21 (39.6) 0.52
Race, n (%) 0.62
 Caucasian 30 (31.9) 14 (34.2) 16 (30.2)
 African American 61 (64.9) 25 (61.0) 36 (67.9)
 Other 3 (3.2) 2 (4.9) 1 (1.9)
Diagnosis, n (%) 0.21
 Major depression 55 (58.5) 25 (45.5) 30 (54.5)
 Bipolar I disorder 39 (41.5) 16 (41.0) 23 (59.0)
Order of visit, n (%) 0.045
 First visit during low pollen season 81 (86.2) 32 (34.0) 49 (52.1)
 First visit during high pollen season 13 (13.8) 9 (9.6) 4 (4.3)
Medications, n (%)
 Mood stabilizers 33 (35.0) 12 (29.3) 21 (39.6) 0.3
 Antidepressants 72 (76.6) 27 (65.9) 45 (84.9) 0.03
 Antipsychotic medications 23 (24.5) 8 (19.5) 15 (28.3) 0.33
 Anxiolytic medications 20 (21.3) 8 (19.5) 12 (22.6) 0.71
 Hypnotic medications 26 (27.7) 7 (17.1) 19 (35.9) 0.044
 Antihistamines 10 (10.6) 5 (12.2) 5 (9.4) 0.67
 Thyroid hormone 14 (14.9) 3 (7.3) 11 (20.8) 0.07
 Stimulants 7 (7.5) 0 (0) 7 (13.2) 0.016
 Opioid (pain control) 4 (4.3) 2 (4.9) 2 (3.8) 0.8
 Others 46 (49.0) 17 (41.5) 29 (54.7) 0.2